159 related articles for article (PubMed ID: 19892796)
1. Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck.
Niu J; Huang YJ; Wang LE; Sturgis EM; Wei Q
Carcinogenesis; 2009 Dec; 30(12):2053-8. PubMed ID: 19892796
[TBL] [Abstract][Full Text] [Related]
2. The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer.
Laczmanska I; Karpinski P; Gil J; Laczmanski L; Makowska I; Bebenek M; Ramsey D; Sasiadek MM
Colorectal Dis; 2017 Jul; 19(7):O272-O278. PubMed ID: 28504867
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study.
Liu Z; Wang L; Wang LE; Sturgis EM; Wei Q
Cancer Lett; 2008 Sep; 268(1):158-65. PubMed ID: 18455294
[TBL] [Abstract][Full Text] [Related]
5. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Amos CI; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Carcinogenesis; 2004 Oct; 25(10):1911-6. PubMed ID: 15180941
[TBL] [Abstract][Full Text] [Related]
6. Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck.
Guo H; Liu H; Wei J; Li Y; Yu H; Guan X; Li-E W; Li G; Sturgis EM; Wei Q; Liu Z
Eur J Cancer; 2014 Feb; 50(3):582-92. PubMed ID: 24295637
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck.
Lu M; Liu Z; Yu H; Wang LE; Li G; Sturgis EM; Johnson DG; Wei Q
Mol Carcinog; 2012 Oct; 51 Suppl 1(Suppl 1):E132-41. PubMed ID: 22344756
[TBL] [Abstract][Full Text] [Related]
8. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
Lei D; Sturgis EM; Wang LE; Liu Z; Zafereo ME; Wei Q; Li G
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1484-91. PubMed ID: 20501759
[TBL] [Abstract][Full Text] [Related]
9. Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck.
Yu H; Liu Z; Huang YJ; Yin M; Wang LE; Wei Q
PLoS One; 2012; 7(7):e41853. PubMed ID: 22848636
[TBL] [Abstract][Full Text] [Related]
10. A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck.
Huang YJ; Niu J; Wei S; Yin M; Liu Z; Wang LE; Sturgis EM; Wei Q
Carcinogenesis; 2010 Dec; 31(12):2082-90. PubMed ID: 20935061
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
[TBL] [Abstract][Full Text] [Related]
12. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.
Sturgis EM; Dahlstrom KR; Spitz MR; Wei Q
Arch Otolaryngol Head Neck Surg; 2002 Sep; 128(9):1084-8. PubMed ID: 12220217
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.
Zhang Z; Wang L; Wei S; Liu Z; Wang LE; Sturgis EM; Wei Q
DNA Repair (Amst); 2010 May; 9(5):558-66. PubMed ID: 20206583
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Shi Q; Sturgis EM; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 2004 Dec; 10(23):7903-10. PubMed ID: 15585623
[TBL] [Abstract][Full Text] [Related]
16.
Tu R; Zhong D; Li P; Li Y; Chen Z; Hu F; Yuan G; Chen Z; Yu S; Song J
Ann Med; 2023; 55(2):2281659. PubMed ID: 38039548
[TBL] [Abstract][Full Text] [Related]
17. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.
Guan X; Liu Z; Liu H; Yu H; Wang LE; Sturgis EM; Li G; Wei Q
FASEB J; 2013 Apr; 27(4):1404-12. PubMed ID: 23271051
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
19. CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.
Chen K; Zhao H; Hu Z; Wang LE; Zhang W; Sturgis EM; Wei Q
Clin Cancer Res; 2008 Oct; 14(19):6343-9. PubMed ID: 18829519
[TBL] [Abstract][Full Text] [Related]
20. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis.
Sturgis EM; Zheng R; Li L; Castillo EJ; Eicher SA; Chen M; Strom SS; Spitz MR; Wei Q
Carcinogenesis; 2000 Dec; 21(12):2219-23. PubMed ID: 11133811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
